Researchers have identified how cells recognize and suppress transposons, mobile DNA elements that can destabilize genomes.
Clinical Supply Agreement to support phase II clinical trial: Cambridge, UK Friday, May 22, 2026, 18:00 Hrs [IST] 4basebio PLC, a company pioneering an enzymatically ...
Morning Overview on MSN
A targeted pill and a custom mRNA vaccine are both beating back pancreatic cancer in early trials — cracking open one of medicine’s hardest tumors
Pancreatic ductal adenocarcinoma has a five-year survival rate of roughly 13 percent, according to the American Cancer ...
What’s New and How It Affects Screening Recommendations for Americans The updated guidelines are a reminder that we ...
Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company leveraging a novel Oligonucleotide Promoted Editing of RNA (OPERA ®) platform to develop a new class of genetic medicines for rare ...
Pharmaceutical giant Eli Lilly has agreed to acquire Engage Biologics for up to $202m in cash, marking another addition to ...
A new AI-based system combines genomic sequences and RNA-binding protein profiles to model complex RNA splicing patterns ...
Scribe Therapeutics, Inc. (Scribe), a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to extend healthy lifespan through disease prevention and ...
Founded in 1848, Teikoku Seiyaku is dedicated to its mission “For a World Without Pain”, leveraging its expertise in transdermal absorption technology. Teikoku Seiyaku develops, manufactures, and ...
Hanzlik's multiple sclerosis was destroying her freedom to live the life she wanted. She gave up her active nursing job for a ...
Oxford Nanopore Technologies PLC (LSE:ONT), the LSE-listed DNA sequencing company, has drawn positive reviews from RBC ...
Perth biotechs Avicena Systems and Syngenis Laboratories are fast-tracking pathogen detection technology to protect Australia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results